Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.

PloS one - 8 Dec 2009

Chevaliez Stéphane, Bouvier-Alias Magali, Brillet Rozenn, Pawlotsky Jean-Michel

Abstract excerpt

BACKGROUND: With the development of new specific inhibitors of hepatitis C virus (HCV) enzymes and functions that may yield different antiviral responses and resistance profiles according to the HCV subtype, correct HCV genotype 1 subtype identification is mandatory in clinical trials for stratification and interpretation purposes and will likely become necessary in future clinical practice. The goal of this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Intergenic
Share to Drug Design

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, Viral

Share to Hepacivirus

Share to Microbiological Techniques

Share to Reagent Kits, Diagnostic

Share to Viral Nonstructural Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 19997618
DOI: 10.1371/journal.pone.0008209
PMCID: PMC2785465

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.PMID 19997618Read ↗

NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.Semantic proximity Read ↗

Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.Semantic proximity Read ↗

Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.Semantic proximity Read ↗

Comparison of line probe assay and DNA sequencing of 5' untranslated region for genotyping hepatitis C virus: description of novel line probe patterns.Semantic proximity Read ↗

Second-generation line probe assay for hepatitis C virus genotypingSemantic proximity Read ↗

Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region.Semantic proximity Read ↗

[Investigation of Hepatitis C Virus (HCV) Genotypes by "Reverse Hybridisation Strip Assay" and DNA Sequence Analysis Methods].Semantic proximity Read ↗

Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.Semantic proximity Read ↗

A rapid real-time PCR assay for determination of hepatitis C virus genotypes 1, 2 and 3a.Semantic proximity Read ↗

Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.Semantic proximity Read ↗

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.Semantic proximity Read ↗

Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.